The Indian pharma industry has been a bit of a no-show in 2007.
On the sales front, the domestic Pharma market grew at 12 per cent in 2007.
The value of deals in the pharma sector in Asia Pacific in 2007 was $8.4 billion, almost twice the value of $4.7 billion a year ago.
Ministry of health and family welfare decision to arm the Drugs and Cosmetics Act to deal with combination drugs known as Fixed Dosage Combination (FDC) was in debate.
The Drug Prices Control Order (DPCO), which lays out prices for most medicines widely available in the country, has proposed to increase the number of drugs under the DPCO-1995 to 354 from the current 74.
Mergers and acquisitions activity has been low. Asian pharma M&As increased to 30% total share of the global pharma M&A pie in 2007 from 23 per cent in 2006.